Mar.30 — Navid Malik, executive director of Life Sciences Division, discusses working with Stabilitech on a vaccine for coronavirus and how long it could be before one is on the market. He speaks on “Bloomberg Markets: European Open.”
In This Story: Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.